Latest News & Updates

Breaking News

  • 12 hours ago

  • Simantini Singh Deo

ModernaTX Gains FDA Approval for MNEXSPIKE mRNA COVID-19 Vaccine Under STN 125835
Breaking News
Steps Biosciences and RDGVRP Launch Dedicated Formulations R&D Centre in Bengaluru

Vaibhavi M.

Alembic Appoints Ramesh Juneja as Executive Vice President for India Human Health Business

Vaibhavi M.

ResMed Acquires Noctrix Health in $340 Million Deal for Sleep Therapy Expansion

Vaibhavi M.

Novo Nordisk Launches Wegovy Oral Tablet in UAE as First International Market Outside US

Vaibhavi M.

Other trending news you may like to read

ModernaTX Gains FDA Approval for MNEXSPIKE mRNA COVID-19 Vaccine Under STN 125835

ModernaTX secures FDA biologics licensure for MNEXSPIKE under STN 125835, with a layered approval record spanning May–September 2025.

Simantini Singh Deo

Pharma Now

Steps Biosciences and RDGVRP Launch Dedicated Formulations R&D Centre in Bengaluru

Steps Biosciences and RDGVRP open a Bengaluru R&D centre targeting sterile injectables and complex drug delivery systems.

Vaibhavi M.

Pharma Now

Alembic Appoints Ramesh Juneja as Executive Vice President for India Human Health Business

Alembic Pharmaceuticals appoints Ramesh Juneja as EVP, Human Health, sharpening domestic commercial leadership amid growing GMP and supply scrutiny.

Vaibhavi M.

Pharma Now

ResMed Acquires Noctrix Health in $340 Million Deal for Sleep Therapy Expansion

ResMed acquires Noctrix Health for $340 million, expanding into neuromuscular sleep therapy and triggering QMS integration work.

Vaibhavi M.

Pharma Now